Article info
Feature article
Not robots: children's perspectives on authenticity, moral agency and stimulant drug treatments
- Correspondence to Dr Ilina Singh, Department of Social Science, Health and Medicine, King's College London, King's Building, Strand, London WC2R 2L, UK;i.a.singh{at}lse.ac.uk
Citation
Not robots: children's perspectives on authenticity, moral agency and stimulant drug treatments
Publication history
- Received October 4, 2011
- Revised May 4, 2012
- Accepted June 5, 2012
- First published August 28, 2012.
Online issue publication
May 19, 2013
Article Versions
- Previous version (28 August 2012).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions This is an open-access article distributed under the terms of the Creative Commons Attribution Non-commercial License, which permits use, distribution, and reproduction in any medium, provided the original work is properly cited, the use is non commercial and is otherwise in compliance with the license. See: http://creativecommons.org/licenses/by-nc/3.0/ and http://creativecommons.org/licenses/by-nc/3.0/legalcode
Other content recommended for you
- Prevalence, determinants and spectrum of attention-deficit hyperactivity disorder (ADHD) medication of children and adolescents in Germany: results of the German Health Interview and Examination Survey (KiGGS)
- Changes in medical use of central nervous system stimulants among US adults, 2013 and 2018: a cross-sectional study
- Assent as an ethical imperative in the treatment of ADHD
- Stimulant drugs for severe hyperactivity in childhood
- What place for ▼lisdexamfetamine in children and adolescents with ADHD?
- Service use in children aged 6–8 years with attention deficit hyperactivity disorder
- Attention deficit and hyperactivity disorder, methylphenidate, and epilepsy
- Childhood attention-deficit/hyperactivity disorder
- Stimulant medication to treat attention-deficit/hyperactivity disorder
- Effects of methylphenidate on cognition and behaviour in children with neurofibromatosis type 1: a study protocol for a randomised placebo-controlled crossover trial